202 related articles for article (PubMed ID: 31870912)
21. C11-hydroxy and C11-oxo C
Gent R; Van Rooyen D; Atkin SL; Swart AC
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203272
[TBL] [Abstract][Full Text] [Related]
22. The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C
Gent R; du Toit T; Bloem LM; Swart AC
J Steroid Biochem Mol Biol; 2019 May; 189():116-126. PubMed ID: 30825506
[TBL] [Abstract][Full Text] [Related]
23. A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
Krishnan AV; Zhao XY; Swami S; Brive L; Peehl DM; Ely KR; Feldman D
Endocrinology; 2002 May; 143(5):1889-900. PubMed ID: 11956172
[TBL] [Abstract][Full Text] [Related]
24. Analysis of 52 C
du Toit T; van Rooyen D; Stander MA; Atkin SL; Swart AC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122243. PubMed ID: 32593151
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
Zhao XY; Malloy PJ; Krishnan AV; Swami S; Navone NM; Peehl DM; Feldman D
Nat Med; 2000 Jun; 6(6):703-6. PubMed ID: 10835690
[TBL] [Abstract][Full Text] [Related]
26. Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.
Hofland J; van Weerden WM; Dits NF; Steenbergen J; van Leenders GJ; Jenster G; Schröder FH; de Jong FH
Cancer Res; 2010 Feb; 70(3):1256-64. PubMed ID: 20086173
[TBL] [Abstract][Full Text] [Related]
27. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
[TBL] [Abstract][Full Text] [Related]
28. Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer.
Mostaghel EA; Zhang A; Hernandez S; Marck BT; Zhang X; Tamae D; Biehl HE; Tretiakova M; Bartlett J; Burns J; Dumpit R; Ang L; Matsumoto AM; Penning TM; Balk SP; Morrissey C; Corey E; True LD; Nelson PS
Clin Cancer Res; 2019 Jan; 25(1):426-439. PubMed ID: 30181386
[TBL] [Abstract][Full Text] [Related]
29. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
31. Activity of melatonin and other pineal indoles on the in vitro synthesis of cortisol, cortisone, and adrenal androgens.
Touitou Y; Bogdan A; Auzéby A; Touitou C
J Pineal Res; 1989; 6(4):341-50. PubMed ID: 2732894
[TBL] [Abstract][Full Text] [Related]
32. Adrenal C11-oxy C
Barnard L; Gent R; van Rooyen D; Swart AC
J Steroid Biochem Mol Biol; 2017 Nov; 174():86-95. PubMed ID: 28774496
[TBL] [Abstract][Full Text] [Related]
33. Absence of 11-keto reduction of cortisone and 11-ketotestosterone in the model organism zebrafish.
Tsachaki M; Meyer A; Weger B; Kratschmar DV; Tokarz J; Adamski J; Belting HG; Affolter M; Dickmeis T; Odermatt A
J Endocrinol; 2017 Feb; 232(2):323-335. PubMed ID: 27927697
[TBL] [Abstract][Full Text] [Related]
34. The influence of Aspalathus linearis (Rooibos) and dihydrochalcones on adrenal steroidogenesis: quantification of steroid intermediates and end products in H295R cells.
Schloms L; Storbeck KH; Swart P; Gelderblom WC; Swart AC
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):128-38. PubMed ID: 22101210
[TBL] [Abstract][Full Text] [Related]
35. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
37. Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.
Suzuki K; Nishiyama T; Hara N; Yamana K; Takahashi K; Labrie F
Prostate Cancer Prostatic Dis; 2007; 10(3):301-6. PubMed ID: 17387321
[TBL] [Abstract][Full Text] [Related]
38. Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats.
Hara T; Kouno J; Kaku T; Takeuchi T; Kusaka M; Tasaka A; Yamaoka M
J Steroid Biochem Mol Biol; 2013 Mar; 134():80-91. PubMed ID: 23146910
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a 20β-HSDH from the anaerobic gut bacterium
Devendran S; Méndez-García C; Ridlon JM
J Lipid Res; 2017 May; 58(5):916-925. PubMed ID: 28314858
[TBL] [Abstract][Full Text] [Related]
40. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
